Community optometrists able to diagnose glaucoma accurately

Article

Community optometrists trained in glaucoma can provide satisfactory decisions regarding diagnosis and initiation of treatment.

Community optometrists trained in glaucoma can provide satisfactory decisions regarding diagnosis and initiation of treatment, according to a report published online ahead of print by the British Journal of Ophthalmology.

Augusto Azuara Blanco and colleagues from the Aberdeen Royal Infirmary and the University of Aberdeen, UK compared the diagnostic abilities of accredited glaucoma optometrists (AGO) with that of routine hospital eyecare against a reference standard of expert opinion, i.e. consultant ophthalmologists with a special interest in glaucoma.

A total of 100 subjects were examined. People suspected of having glaucoma underwent full assessment both in the newly established, optometry led glaucoma management scheme and in a consultant led hospital eye service.

Agreement between the AGO and consultant ophthalmologists was significant at 89%. Agreement regarding the need for treatment was also substantial (88%) whilst the agreement between trainee ophthalmologist and consultant ophthalmologist was moderate (83%).

It was concluded that community optometrists trained in glaucoma are able to offer satisfactory diagnoses and initiation of treatment.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
© 2025 MJH Life Sciences

All rights reserved.